| Trial Identifier: | D6132C00001 |
| Sponsor: | AstraZeneca |
| Start Date: | February 2021 |
| Primary Completion Date: | June 2022 |
| Study Completion Date: | December 2025 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version | |
| Spanish Translation | |
| Polish Translation | |
| Korean Translation |
| Country | Location |
|---|---|
| ES | Sevilla, ES, 41071 |
| ES | Valencia, ES, 46015 |
| KR | Cheongju-si, KR, 28644 |
| KR | Jinju-si, KR, 52727 |
| KR | seoul, KR, 06351 |
| KR | Seoul, KR, 03722 |
| KR | Seoul, KR, 06591 |
| KR | Seoul, KR, 05505 |
| PL | Bydgoszcz, PL, 85-796 |
| PL | Olsztyn, PL, 10-357 |
| PL | Poznan, PL, 60-693 |
| US, MI | Grand Rapids, MI, US, 49503 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company